ArticlePloS one2017

Correction: Novel Synthetic Oxazines Target NF-κB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo.

Anilkumar C Nirvanappa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.